Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Adial Pharmaceuticals Inc

Current price
1.93 USD -0.11 USD (-5.39%)
Last closed 2.17 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 9 447 823 USD
Yield for 12 month +639.18 %
21.11.2021 - 28.11.2021

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Address: 1180 Seminole Trail, Charlottesville, VA, United States, 22901

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

17 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-564 USD

Last Year

-60 501 USD

Current Quarter

-141 USD

Last Quarter

-141 USD

Key Figures ADIL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 887 383 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -82.24 %
PEG Ratio
Return On Equity TTM -190.27 %
Wall Street Target Price 17 USD
Revenue TTM
Book Value 2.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -4.91 USD
Diluted Eps TTM -4.91 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADIL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADIL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 07.08.2023
Dividend Date

Stock Valuation ADIL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.0641
Price Book MRQ 2.3136

Financials ADIL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADIL

For 52 weeks

0.77 USD 14 USD
50 Day MA 1.54 USD
Shares Short Prior Month 105 627
200 Day MA 2.8 USD
Short Ratio
Shares Short 8 655
Short Percent 0.56 %

Dynamics of changes in the value of assets




399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds



207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics



2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics